2024-09-18 - Analysis Report
##  ABT Stock Analysis Report

**Company Overview:** Abbott Laboratories (ABT) is a global healthcare company that develops, manufactures, and markets a wide range of products, including pharmaceuticals, medical devices, diagnostics, and nutritionals.

**Performance Analysis:**

1. **Return on Investment:** 
    * ABT's cumulative return over the period is 47.11%, lagging behind the S&P 500 (VOO) which has a cumulative return of 88.56%. 
    * This results in a divergence of -41.45%, indicating that ABT has underperformed the benchmark by a significant margin. The relative divergence of 21.66% suggests that this underperformance is within the historical range of its volatility.

2. **Recent Price Movement:**
    * The closing price of ABT is $117.59.
    * The 5-day moving average is $117.01, indicating short-term stability. 
    * The 20-day moving average is $114.31, suggesting a mild upward trend.
    * The 60-day moving average is $108.68, indicating a longer-term upward trajectory.

3. **Technical Indicators:**
    * The RSI (71.9) indicates that ABT is currently in overbought territory, suggesting potential for a pullback.
    * The PPO (0.09) indicates a bullish momentum, but it's not as strong as the RSI reading.
    * The recent relative divergence of 7.21 suggests a short-term upward trend, indicating potential for a continued rise in price.
    * The expected return of 24.94% represents the potential maximum return over the next 5 years based on current investments.

4. **Recent Earnings and Outlook:**
    * Recent earnings have shown a stable trend, with the latest earnings exceeding expectations.
    * **| Date | EPS | Revenue |**
    |---|---|---|
    | 2024-07-31 | 0.74 | 10.38 B$ |  (**Exceeded expectations**)
    | 2024-05-02 | 0.7 | 9.96 B$ |
    | 2023-11-01 | 0.82 | 10.14 B$ |
    | 2023-08-03 | 0.79 | 9.98 B$ |
    | 2024-07-31 | 0.79 | 9.98 B$ |
    * The company has demonstrated consistent revenue growth and profitability, indicating a healthy financial position.

**Overall Analysis:**

ABT is a financially stable company with a proven track record of growth and profitability. However, its recent underperformance compared to the S&P 500 and the overbought conditions suggest potential for a correction. While the technical indicators suggest a short-term upward trend, investors should monitor the stock closely for signs of a pullback. The strong earnings performance and the long-term growth prospects make ABT a potentially attractive investment for long-term investors with a moderate risk appetite. 
